Located on Manhattan’s Upper East Side, the David H. Koch Center will offer outpatient services when it opens in 2018.
Feb 22, 2016
NewYork-Presbyterian held a beam signing ceremony yesterday to mark the installation of the final beam in the David H. Koch Center. The state-of-the-art ambulatory care facility is expected to open in 2018, and is supported by an extraordinary $100 million gift from David H. Koch.
Attendees included Dr. Steven J. Corwin, president and CEO of NewYork-Presbyterian, Dr. Laura L. Forese, executive vice president and chief operating officer of NewYork-Presbyterian, and Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine.
“On behalf of NewYork-Presbyterian and our Board of Trustees, it’s an honor to celebrate our progress on the David H. Koch Center,” said Dr. Corwin. “As the healthcare landscape continues to evolve, patients are increasingly seeking high quality care in an outpatient setting. We deeply appreciate David’s leadership, vision and generosity in working with us to build a center that will revolutionize care for New Yorkers.”
“Today’s ceremonial beam signing and topping-out celebration gives me enormous satisfaction that this site will soon become one of the finest ambulatory care centers dedicated to excellence in healthcare and personalized treatment,” said David H. Koch. “I am honored to participate in this important milestone and contribute to NewYork-Presbyterian’s future success.”
Located in Manhattan’s Upper East Side on York Avenue between 68th and 69th Streets, the David H. Koch Center is designed to provide patients with high quality, personalized care in a comfortable, technologically sophisticated setting. Once complete, the 750,000-square foot facility will offer a range of services, including multidisciplinary care for digestive diseases, cancer, eye diseases and other conditions, as well as outpatient surgery, interventional radiology, diagnostic imaging, preadmission testing and a wellness center. An important feature of the center will be its ability to accommodate new technology as patient care treatment evolves in the future.
The Alexandra & Steven Cohen Hospital for Women and Newborns will also be housed in the David H. Koch Center. Occupying the top six floors, the new, state-of-the-art hospital for pre- and post-natal care will be the first of its kind in the New York tri-state area.
David H. Koch has been a member of the Board of Trustees of NewYork-Presbyterian since 1988. He currently chairs the board’s development committee and sits on its real estate committee.
NewYork-Presbyterian is one of the nation’s most comprehensive healthcare delivery networks, focused on providing innovative and compassionate care to patients in the New York metropolitan area and throughout the globe. In collaboration with two renowned medical school partners, Weill Cornell Medicine and Columbia University College of Physicians & Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and clinical innovation.
NewYork-Presbyterian has four major divisions: NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the magazine’s Honor Roll of best hospitals in the nation; NewYork-Presbyterian Regional Hospital Network is comprised of leading hospitals in and around New York and delivers high-quality care to patients throughout the region; NewYork-Presbyterian Physician Services connects medical experts with patients in their communities; and NewYork-Presbyterian Community and Population Health features the hospital’s ambulatory care network sites and operations, community care initiatives and healthcare quality programs, including NewYork Quality Care, established by NewYork-Presbyterian, Weill Cornell and Columbia.
NewYork-Presbyterian is one of the largest healthcare providers in the U.S. Each year, nearly 29,000 NewYork-Presbyterian professionals deliver exceptional care to more than 2 million patients.
For more information, visit www.nyp.org and find us on Facebook, Twitter and YouTube.
David H. Koch
David H. Koch is an executive vice president and a board member of Koch Industries, Inc. and also serves as chairman of the board and chief executive officer of Koch Chemical Technology Group, LLC, a wholly owned subsidiary of Koch Industries.
A long-time philanthropist and cancer survivor, Mr. Koch has given generously to a variety of cultural and medical organizations and programs. In his lifetime, he and the David H. Koch Charitable Foundation have pledged or contributed nearly $1.2 billion to cancer research, medical centers, educational institutions, arts and cultural institutions, and to assist public policy organizations.
In 2005, Mr. Koch received a presidential appointment to the National Cancer Advisory Board of the National Cancer Institute, serving until March 2010 when his term expired. Mr. Koch has been recognized by The New York Academy of Medicine for his support of biomedical research, healthcare and education (2004). His corporate leadership has been honored by the Cold Spring Harbor Laboratory’s Double Helix Award (2007), Memorial Sloan-Kettering Cancer Center’s Excellence in Corporate Leadership Award (2005) and the prestigious Corporate Citizenship Award from the Woodrow Wilson International Center for Scholars (2004). Other recognition includes the Massachusetts Institute of Technology’s Bronze Beaver Award (2008) and Hospital for Special Surgery’s Philanthropy Award (2009).
Mr. Koch was born in Wichita, Kansas, and earned bachelor’s and master’s degrees in chemical engineering from the Massachusetts Institute of Technology. He and his wife, Julia, have three children.